Literature DB >> 23105527

Prevalence of insulin resistance in first degree relatives of type-2 diabetes mellitus patients: A prospective study in north Indian population.

Arvind Kumar1, Poornima Tewari, Sibasis S Sahoo, Arvind Kumar Srivastava.   

Abstract

A total of 172 first degree relatives (FDRs) and 178 controls were included in this study. All the cases and controls were subjected to various anthropometric measurements, fasting and postprandial glucose estimation, fasting insulin measurement and fasting lipid profile. Results revealed the prevalence of Impaired Fasting Glucose (IFG) (cases 37% Vs controls 11.6%), Impaired Glucose Tolerance (IGT) (cases 34.3% Vs controls 11.2%) and diabetes (cases 11.05% controls 3.37%) was significantly higher in first degree relatives. Insulin resistance was measured using various methods, which included fasting plasma insulin (FPI), Homeostasis Model Assessment for Insulin Resistance (HOMA(IR)), insulin sensitivity index (ISI) (Mffm/l). Prevalence of insulin resistance (Insulin Resistance) as observed comparing FPI and HOMA(IR) in cases and controls was 43.6% and 11.24% (P=0.005) and 37.8% and 12.47% (P=0.000) respectively. Prevalence of IR (Insulin Resistance) observed in cases having Normal Glucose Tolerance (NGT), Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) and diabetes mellitus measuring FPI Vs HOMA(IR) was 37.5% vs 30.2%, 45% vs 40%, 38.98% vs 37.28% and 36.84% vs 31.57% as accordingly. However, ISI (Mffm/l) was not found to be a promising index for IR due to its poor specificity. Though HOMA is taken as gold standard for measurement of IR globally, our study observed fasting plasma insulin representing high sensitivity (89.7%) and specificity (93.3%) as compared to HOMA. Thus FPI had emerged in this work as a simple and reliable test for diagnosing insulin resistance across the population susceptible to develop diabetes including FDRs.

Entities:  

Keywords:  FDR (First Degree Relatives); FPI (Fasting Plasma Insulin); HOMAIR (Homeostasis Model Assessment for Insulin Resistance); IFG (Impaired Fasting Glucose); IGT (Impaired Glucose Tolerance); IR (Insulin Resistance); ISI (Insulin Sensitivity Index); Mffm/l (Insulin sensitivity index corrected for fat-free mass)

Year:  2005        PMID: 23105527      PMCID: PMC3453841          DOI: 10.1007/BF02867394

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  14 in total

1.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

2.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

3.  Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.

Authors:  M Emoto; Y Nishizawa; K Maekawa; Y Hiura; H Kanda; T Kawagishi; T Shoji; Y Okuno; H Morii
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

4.  Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.

Authors:  A Volk; W Renn; D Overkamp; B Mehnert; E Maerker; S Jacob; B Balletshofer; H U Häring; K Rett
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

5.  Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

Authors:  D Tripathy; M Carlsson; P Almgren; B Isomaa; M R Taskinen; T Tuomi; L C Groop
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

6.  Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus.

Authors:  J M Olefsky; O G Kolterman; J A Scarlett
Journal:  Am J Physiol       Date:  1982-07

7.  High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.

Authors:  A Costa; M Rios; R Casamitjana; R Gomis; I Conget
Journal:  Diabetes Res Clin Pract       Date:  1998-09       Impact factor: 5.602

8.  Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.

Authors:  W Y Fujimoto; D L Leonetti; J L Kinyoun; W P Shuman; W C Stolov; P W Wahl
Journal:  Diabetes       Date:  1987-06       Impact factor: 9.461

9.  Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians.

Authors:  K Osei; D A Cottrell; C A Adenuwon; E C Ezenwaka; A O Akanji; T M O'Dorisio
Journal:  Diabetes Care       Date:  1993-10       Impact factor: 19.112

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  4 in total

1.  The serum C Peptide levels among the offsprings of the people with type 2 diabetes.

Authors:  Gaurav Kumar; Jayballabh Kumar; Farhan Ahmad Khan; Devesh Kumar; Kiran Malik
Journal:  J Clin Diagn Res       Date:  2013-02-15

2.  Long-Term Efficacy and Safety of Empagliflozin Monotherapy in Drug-Naïve Patients with Type 2 Diabetes in Indian Subgroup: Results from a 76-week Extension Trial of Phase III, Double-Blind, Randomized Study.

Authors:  Sunil Gupta; Shehla Shaikh; Pooja Joshi; Shraddha Bhure; Viraj Suvarna
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr

3.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

4.  Frequency of impaired fasting glucose in first degree relatives of Type-II diabetic patients and its association with Body Mass Index.

Authors:  Alia Ali; Azeem Taj; Muhammed Uthman Ahmed; Elsa Tabrez
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.